---
title: "Rocket制药 (RCKT.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/RCKT.US/norm.md"
symbol: "RCKT.US"
name: "Rocket制药"
parent: "https://longbridge.com/zh-CN/quote/RCKT.US.md"
datetime: "2026-05-20T09:40:20.903Z"
locales:
  - [en](https://longbridge.com/en/quote/RCKT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RCKT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RCKT.US/norm.md)
---

# Rocket制药 (RCKT.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.4244 | -0.3805 | -0.4511 | -0.6208 | -0.5571 |
| ROE | -73.89% | -57.59% | -60.29% | -71.95% | -56.05% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -47.59M | -42.54M | -50.33M | -68.92M | -61.33M |
| 营业利润 | -48.51M | -44.03M | -52.42M | -67.68M | -64.39M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 285.41M | 330.45M | 368.03M | 420.98M | 471.07M |
| 权益乘数 | 1.20 | 1.19 | 1.17 | 1.19 | 1.14 |
| 每股净资产 | 2.18 | 2.56 | 2.90 | 3.28 | 3.86 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 144.38M | 188.93M | 222.76M | 271.49M | 318.16M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 69.45M | 71.59M | 74.17M | 77.64M | 80.39M |
| 净债务 | -119.61M | -164.05M | -197.71M | -246.29M | -292.81M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -45.39M | -34.84M | -50.42M | -48.96M | -55.79M |
| 投资现金流 | 17.45M | 36.42M | 93.62M | 31.76M | -58.03M |
| 融资现金流 | -1000.00 | 0.0000 | -67000.00 | 215000.00 | - |
| 自由现金流 | -27.17M | -19.12M | -31.22M | -20.17M | -33.16M |
| 现金流充裕率 | -48291.49% | -43550.00% | 93370.37% | -97928.00% | -15326.92% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -93000.00 | -80000.00 | 54000.00 | -50000.00 | -364000.00 |